Medtronic finally unveils its new robot-assisted surgery system

Medtronic (NYSE:MDT) claims it has a new robot-assisted surgery platform that is more flexible and cost-effective than systems presently on the market.

That appeared to be the message out today from the world’s largest medical device company as it unveiled its much-awaited Hugo RAS system. The system is Medtronic’s answer to a growing market that remains dominated by Intuitive Surgical (NSDQ:ISRG) and its da Vinci SP.

During an investor update held today in Hartford, Conn., Medtronic EVP Bob White repeatedly claimed that only 2% of surgeries around the world are held with the assistance of robots.

“There’s 98% out there that needs to be done via robotically-assisted surgery but not today because of the cost and utilization burdens,” said White, who is president of the Medtronic’s Minimally Invasive Therapies Group.

Said CEO Omar Ishrak: “In 10 years, not only this robot but other robots we have going will change the face of surgery.”

Medtronic plans to launch the Hugo system in undisclosed places outside the U.S. early the next year, allowing the company to start gathering clinical data, White said. CE Mark and U.S. IDE submissions will follow later in the year, with a goal of achieving U.S. 510(k) clearance in about two years.

By  | MassDevice

Image Credit: Medtronic


About Peter Coffaro 506 Articles
Peter Coffaro is a growth-driven and strategic executive with over 25 years of progressive management success in the medical device industry. With a proven track record and recognized expertise, Peter has established himself as one of the top influencers in medical sales, as acknowledged by prestigious publications such as the World Journal of Orthopedics, Exponential Healthtech, and Throughout his career, Peter has accumulated 10 years of combined sales management experience, excelling in various roles including Director, General Manager, Distributor, and Vice President. He has worked for industry-leading orthopedic companies such as Zimmer, DePuy, and Stryker, solidifying his deep knowledge and network within the field. Peter’s passion for innovation and emerging technologies led him to found OrthoFeed, an award-winning blog covering digital orthopedic news and emerging medical technologies. Through this platform, he stays at the forefront of the industry and contributes to the dissemination of valuable insights. Peter is a three-time Hall of Fame award winner at Johnson and Johnson, demonstrating his exceptional contributions and impact on the organization. His expertise extends to areas such as organizational development, business development, sales management, digital marketing, and professional education. Peter earned a B.S. degree in Biology and Chemistry from Northern Illinois University, further complementing his comprehensive understanding of the medical field. With his wealth of experience, strategic mindset, and dedication to advancing healthcare, Peter Coffaro is a valuable asset and leader in the medical device industry.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.